Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-151417
Filing Date
2026-04-10
Accepted
2026-04-10 17:00:20
Documents
19
Period of Report
2026-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A amrn-20260410.htm   iXBRL DEF 14A 3267642
2 GRAPHIC img20107485_0.jpg GRAPHIC 7999
3 GRAPHIC img20107485_1.gif GRAPHIC 108233
4 GRAPHIC img20107485_2.gif GRAPHIC 87127
5 GRAPHIC img20107485_3.gif GRAPHIC 101834
6 GRAPHIC img20107485_4.gif GRAPHIC 862
7 GRAPHIC img20107485_5.gif GRAPHIC 862
8 GRAPHIC img20107485_6.gif GRAPHIC 874
  Complete submission text file 0001193125-26-151417.txt   5608112

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20260410.xsd EX-101.SCH 40615
22 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20260410_htm.xml XML 476578
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21392 | Film No.: 26855619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)